Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusion therapy.

L T Goodnough1

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. goodnough@labmed.wustl.edu

Journal of Clinical Apheresis
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfusion medicine fellowship training in the United States and the UK: a clinical Fellow's experience.

Transfusion medicine (Oxford, England)·2019
Same author

The effects of monoclonal anti-CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia.

Transfusion·2019
Same author

Acute Normovolemic Hemodilution in Surgery.

Hematology (Amsterdam, Netherlands)·2016
Same author

Parenteral Iron and Recombinant Human Erythropoietin Therapy to Stimulate Erythropoiesis in Patients Undergoing Repair of Hip Fracture.

Hematology (Amsterdam, Netherlands)·2016
Same author

The scientific basis for patient blood management.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2015
Same author

Cryoprecipitate therapy.

British journal of anaesthesia·2014
Same journal

Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee.

Journal of clinical apheresis·2026
Same journal

The Role of Therapeutic Apheresis in the Management of Rheumatoid Arthritis A Systematic Review and Meta-Analysis.

Journal of clinical apheresis·2026
Same journal

Thrombocytapheresis as a Bridge Intervention in JAK2-Mutant Myeloproliferative Neoplasm Complicated by Acquired von Willebrand Disease: A Case Report.

Journal of clinical apheresis·2026
Same journal

Plerixafor Plus G-CSF Versus Etoposide Combined With Cyclophosphamide and G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Single Center Observational Propensity Score-Matched Cohort Study.

Journal of clinical apheresis·2026
Same journal

Beyond the Centrifuge: Is FcRn Inhibition Ready to Replace Apheresis in Treatment of Guillain-Barré Syndrome?

Journal of clinical apheresis·2026
Same journal

Correction to "Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System".

Journal of clinical apheresis·2026
See all related articles

Apheresis platelets and pooled platelet concentrates are being compared for safety, cost, and inventory. Photochemical inactivation may shift the debate towards cost and inventory, impacting blood policy.

Area of Science:

  • Transfusion Medicine
  • Blood Banking

Background:

  • The debate between apheresis platelets and pooled platelet concentrates involves safety, inventory, and cost considerations.
  • Emerging photochemical inactivation technologies may influence the choice between these platelet products.

Purpose of the Study:

  • To analyze the evolving debate on apheresis platelets versus pooled platelet concentrates.
  • To explore the potential impact of photochemical inactivation on the use of apheresis platelets.
  • To examine the relationship between platelet inventory, donor pools, and national blood policy.

Main Methods:

  • Comparative analysis of apheresis platelet and pooled platelet concentrate characteristics.
  • Evaluation of the role of photochemical inactivation in platelet safety and utilization.

Related Experiment Videos

  • Assessment of inventory management and donor pool dynamics in blood banking.

    • Main Results:

    • Photochemical inactivation may reduce the need for apheresis-specific rationale, focusing debate on cost and inventory.
    • Apheresis platelet dosing depends on donor platelet count and yield.
    • Increased apheresis platelet inventory correlates with decreased whole blood inventory.

    Conclusions:

    • The future use of apheresis platelets versus pooled platelet concentrates will likely hinge on economic and inventory factors.
    • Further research is required to understand the implications of distinct donor pools on national blood policy.
    • Photochemical inactivation is a key technology influencing the comparative value of platelet products.